Prognostic impact of heart failure phenotype on survival after endovascular therapy for peripheral artery disease: Insights from the multicenter retrospective SETers study
Yuki Shima(Kurashiki Central Hospital), Mitsuru Abe(Kyoto Medical Center), Shingo Kurimoto(Tokushima Red Cross Hospital), Eiji Karashima(Shimonoseki City Hospital), Takashi Shimonaga, Gakuto Bando(Kurashiki Central Hospital), Yoji Urabe, Akira Takashima(Taoka Hospital), Naoya Inoue(Kurashiki Central Hospital), Yasunori Arai(Fukuyama City Hospital), Hironobu Toda(Okayama University), Kohei Kawamura(Okayama Prefecture), Tomohiro Yoshino, Narumi Irie(Kurashiki Central Hospital), Yusuke Kobayashi(Hiroshima City Asa Citizens Hospital), Kazunori Mushiake(Kurashiki Central Hospital), Takanobu Okazaki(Hiroshima General Hospital), Naoto Ohsawa
Cited by 0
Related Papers
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
|JAMA Cardiology|2022|313
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
|Circulation|2018|245
Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent
|Journal of the American College of Cardiology|2013|204
Angiography of small hepatocellular carcinomas: analysis of 105 resected tumors
|American Journal of Roentgenology|1986|115